Please assess the completion status of the following clinical trial:

Trial Title: Constitution of a Biological Cohort Following Bone Marrow Sampling From MDS or AML Patients and Age-matched Healthy Donors

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_CONTROL
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients with diagnosed myelodysplasia or acute myeloid leukemia (study place: ICLN) - Specific to the cases cohort~* Age-matched healthy donors undergoing a cardiovascular surgery - Specific to the control cohort~* Signed written informed consent form~* Patient affiliated to a social security regimen or beneficiary of the same~Exclusion Criteria:~* Medical history of hematological disorders~* Thrombocytopenia, anemia...~* Patient under guardianship or deprived of his liberty or any condition that may affect the patient's ability to understand and sign the informed consent (art. L.1121-6, L.112-7, L.1211-8, L.1211-9)~* Pregnant or breastfeeding women~* Refusing participation

- Gender: ALL
- Minimum Age: 50 Years
- Maximum Age: 80 Years
- Healthy Volunteers: t

Study Arms:
- Acute Myeloid Leukemia patients (Type: None): For diagnosis purpose, bone marrow sampling is performed for acute myeloid leukemia patients. 2 milliliters of this sample will be collected and analysed for the COSMOS study.
- Healthy donors (Type: None): Healthy donors are patients undergoing cardio-vascular surgery for their usual support. During this surgery, 2 milliliters of the bone marrow will be collected, and analysed for the COSMOS study.

Based on this trial design, predict the completion outcome and termination type (if applicable).